News & Updates

Show Multimedia Only

Antidepressants and electroconvulsive therapy may reduce all-cause mortality in depression

19 Sep 2025 by

In patients with depression, antidepressant use may lower all-cause mortality risk, while electroconvulsive therapy (ECT) is associated with reduced risks of all-cause, natural-cause, and suicide-related death, researchers from the University of Hong Kong (HKU) have reported.

Antidepressants and electroconvulsive therapy may reduce all-cause mortality in depression

19 Sep 2025

Mepolizumab cuts exposure to OCS in severe eosinophilic asthma

14 Sep 2025

In patients with severe eosinophilic asthma, treatment with mepolizumab reduces exposure to toxic levels of oral corticosteroids (OCS) and, in turn, the incidence of associated complications, according to a real-world study.

Mepolizumab cuts exposure to OCS in severe eosinophilic asthma

14 Sep 2025

Hydrogen–oxygen therapy alleviates sleep disorders and improves mood

12 Sep 2025 by

Inhalation of a low-dose mixture of hydrogen and oxygen effectively improves sleep quality and mood through its antioxidant properties, by reducing wake time, enhancing sleep quality and relieving psychological stress, a Chinese study has found.

Hydrogen–oxygen therapy alleviates sleep disorders and improves mood

12 Sep 2025

Oral pharmaceutical LSD formulation beneficial in generalized anxiety disorder

11 Sep 2025 by

A single administration of MM120, a semisynthetic pharmaceutical formulation of lysergic acid diethylamide (LSD), helps ease symptoms in patients with moderate to severe generalized anxiety disorder (GAD), as shown in a phase IIB study.

Oral pharmaceutical LSD formulation beneficial in generalized anxiety disorder

11 Sep 2025

Semaglutide safe for schizophrenia patients with prediabetes, obesity

11 Sep 2025

Weekly treatment with semaglutide yields reductions in HbA1c and weight in schizophrenia patients with prediabetes and obesity without worsening mental health, according to a study.

Semaglutide safe for schizophrenia patients with prediabetes, obesity

11 Sep 2025

Neuropsychiatric AEs resolve after switch to doravirine-based ARV regimens

10 Sep 2025 by

Switching to a doravirine-based ARV regimen resolves neuropsychiatric AEs that were ongoing during a prior efavirenz-based regimen in DRIVE-AHEAD, with few events persisting 96 weeks after switching — a finding also seen in DRIVE-FORWARD, as shown in post hoc analyses of the OLEs of the two phase III trials

Neuropsychiatric AEs resolve after switch to doravirine-based ARV regimens

10 Sep 2025

Sleep duration mediates link between screen time in late childhood and depression

08 Sep 2025

Children who spend more screen time are at increased risk of having more depressive symptoms, potentially due to shorter sleep and worse white matter organization during early adolescence, according to a study.

Sleep duration mediates link between screen time in late childhood and depression

08 Sep 2025

Is selective dorsal neurectomy/cryoablation effective for premature ejaculation?

07 Sep 2025

The use of selective dorsal neurectomy (SDN)/cryoablation (CA) as a treatment option for patients with premature ejaculation remains controversial, according to a study. SDN/CA affects intravaginal ejaculatory latency time (IELT) and patient satisfaction.

Is selective dorsal neurectomy/cryoablation effective for premature ejaculation?

07 Sep 2025

Sleep disturbance in epilepsy linked to affective disorders, reduced quality of life

05 Sep 2025

People with epilepsy often experience sleep disturbance, which is linked to other problems such as anxiety and depression and negatively affects quality of life (QoL), according to a study from Germany.

Sleep disturbance in epilepsy linked to affective disorders, reduced quality of life

05 Sep 2025

Quitting smoking may help recovery from substance use disorders

04 Sep 2025 by

Smoking cessation is associated with sustained recovery from substance use disorders (SUDs), according to a longitudinal cohort study funded by the US National Institutes of Health (NIH).

Quitting smoking may help recovery from substance use disorders

04 Sep 2025

News & Updates

Filter by Specialty:

Specialty:

Antidepressants and electroconvulsive therapy may reduce all-cause mortality in depression

Antidepressants and electroconvulsive therapy may reduce all-cause mortality in depression

Mepolizumab cuts exposure to OCS in severe eosinophilic asthma

Mepolizumab cuts exposure to OCS in severe eosinophilic asthma

Hydrogen–oxygen therapy alleviates sleep disorders and improves mood

Hydrogen–oxygen therapy alleviates sleep disorders and improves mood

Oral pharmaceutical LSD formulation beneficial in generalized anxiety disorder

Oral pharmaceutical LSD formulation beneficial in generalized anxiety disorder

Semaglutide safe for schizophrenia patients with prediabetes, obesity

Semaglutide safe for schizophrenia patients with prediabetes, obesity

Neuropsychiatric AEs resolve after switch to doravirine-based ARV regimens

Neuropsychiatric AEs resolve after switch to doravirine-based ARV regimens

Sleep duration mediates link between screen time in late childhood and depression

Sleep duration mediates link between screen time in late childhood and depression

Is selective dorsal neurectomy/cryoablation effective for premature ejaculation?

Is selective dorsal neurectomy/cryoablation effective for premature ejaculation?

Sleep disturbance in epilepsy linked to affective disorders, reduced quality of life

Sleep disturbance in epilepsy linked to affective disorders, reduced quality of life

Quitting smoking may help recovery from substance use disorders

Quitting smoking may help recovery from substance use disorders